Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-08-29 18:02:41
Reporting Period:
Filing Date:
Accepted Time:
2014-08-29 18:02:41
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1323113 Jr N Daniel Swisher C/o Sunesis Pharmaceuticals, Inc.
395 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-27 5,000 $2.09 159,073 No 4 M Direct
Common Stock Disposition 2014-08-27 5,000 $8.00 154,073 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-08-27 5,000 $0.00 5,000 $2.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
710,611 2021-06-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 129,136 Indirect See footnote
  1. The number of shares includes 1,667 shares that the reporting person acquired from an ESPP purchase on May 30, 2014.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2013.
  3. The shares are held by the Swisher Revocable Trust for which reporting person is the Trustee.
  4. One forty-eighth (1/48th) of the shares vest monthly from 6/30/11.